Annukka Pasanen

ORCID: 0000-0002-0079-9807 · 6 papers in corpus
other 2022
Gynecologic Oncology ·doi:10.1016/j.ygyno.2022.03.016

BACKGROUND: Clear cell and endometrioid ovarian carcinomas (OCC and OEC, respectively) have a presumed origin in endometriosis and share molecular alterations with each other and with their endometrial counterparts. The Cancer Genome Atlas …

article 2018
·doi:10.1158/1538-7445.am2018-4611

Abstract Uterine adenomyosis is a condition in which ectopic endometrial glands are present in myometrial stroma surrounded by smooth muscle cell hyperplasia. Foci of adenomyosis growing as a tumor like mass are called adenomyomas. Uterine …

article 2018
·doi:10.1158/1538-7445.am2018-lb-375

Abstract Uterine adenomyosis is a relatively common disorder characterized by the abnormal presence of endometrial glands and stroma in the myometrium. The estimated prevalence of adenomyosis varies between 20-30% in hysterectomy specimens.…

2018
eLife ·doi:10.7554/elife.37110

Uterine leiomyomas (ULs) are benign tumors that are a major burden to women's health. A genome-wide association study on 15,453 UL cases and 392,628 controls was performed, followed by replication of the genomic risk in six cohorts. Effects…

2018
Human reproduction open ·doi:10.1093/hropen/hoy020

Study questionDo the uterine leiomyoma driver events - mediator complex subunit 12 (MED12) mutations, high mobility group AT-hook (HMGA2) overexpression, and fumarate hydratase (FH) inactivation - also contribute to the development of uteri…

article 2015
Duodecim; laaketieteellinen aikakauskirja

Endometriosis is an estrogen dependent disease, which causes chronic inflammation and may lead to pelvic pain and infertility. Women with endometriosis have a 1.5 to 2-fold risk for ovarian epithelial cancer. The risk is increased especiall…